What is Zika and how it spreads
Zika virus is a flavivirus primarily transmitted to people through the bite of an infected Aedes species mosquito, most commonly Aedes aegypti and, to a lesser extent, Aedes albopictus. These mosquitoes are day-biters and thrive in tropical, subtropical, and some temperate regions. Zika can also spread through sexual transmission, from mother to fetus during pregnancy, via blood transfusion, and through laboratory exposure. The virus was first identified in Uganda in 1947 and has since spread to multiple regions, with notable outbreaks in the Americas starting in 2015. Unlike some mosquito-borne diseases, many Zika infections are mild or asymptomatic, but the virus poses serious risks for pregnant people.
Key facts at a glance
| Attribute | Verified detail | Source type |
|---|---|---|
| Primary mosquito vectors | Aedes aegypti and Aedes albopictus | Health authorities and peer-reviewed entomology |
| Typical symptoms | Fever, rash, conjunctivitis, muscle and joint pain, headache | Clinical case series and WHO summaries |
| Incubation period | 3–14 days after mosquito bite | Observational studies and guidance documents |
| Sexual transmission documented | Yes, primarily via semen | Public health reports and case investigations |
| Link to congenital anomalies | Birth defects, including microcephaly, when infection occurs during pregnancy | Epidemiological studies and maternal–fetal health surveillance |
Common symptoms and clinical course
Zika virus disease is usually mild. When symptoms occur, they commonly include fever, rash, conjunctivitis, persistent muscle and joint pain, and headache, generally appearing 3 to 14 days after a mosquito bite. Symptoms typically last several days to a week and rarely require hospitalization. Many infections are asymptomatic, which can make it difficult to know when exposure occurred. Because these features overlap with dengue and chikungunya, healthcare providers may use specific testing to confirm Zika during periods of local transmission. Diagnosis is commonly made using blood or urine tests that detect viral RNA or antibodies.
Risks to pregnancy and fetal development
Zika infection during pregnancy is a significant public health concern because the virus can cross the placenta and affect the developing fetus. The most well-established outcome is congenital Zika syndrome, which can include microcephaly (a smaller-than-expected head size), brain abnormalities, eye defects, and joint problems. Infants with congenital Zika may experience long-term developmental and neurological challenges. The risk of these outcomes is highest when infection occurs in the first and second trimesters, but there is no completely safe period during pregnancy. Pregnant people and those planning pregnancy should avoid travel to areas with ongoing Zika transmission and follow strict mosquito bite prevention.
Prevention and personal protection measures
Because there is no vaccine or specific antiviral treatment for Zika, preventing mosquito bites is the most reliable strategy. Key preventive actions include using EPA-registered insect repellent, wearing long-sleeved shirts and long pants, staying in places with screens and air conditioning, and sleeping under bed nets when necessary. Eliminate or manage standing water around homes, as Aedes mosquitoes can breed in small containers. For people who could become pregnant, partners should also take precautions, because Zika can be transmitted sexually. Travelers to areas with Zika should check current guidance and consider postponing nonessential visits, particularly if pregnant or planning pregnancy.
Global presence and where Aedes mosquitoes live
Aedes aegypti and Aedes albopictus are distributed across many regions, including parts of Africa, the Americas, Southeast Asia, and the Western Pacific. These mosquitoes thrive in urban and peri-urban environments where artificial containers provide breeding sites. Climate and international travel influence where local transmission can occur, with seasonal patterns in some areas. Local spread is more likely when mosquitoes are present, infected people introduce the virus, and populations have little prior immunity. Monitoring mosquito distribution and human cases helps public health officials plan targeted interventions and communicate risk to communities.
Diagnosis, testing, and when to seek care
If you suspect Zika, consult a healthcare provider, especially if you are pregnant or planning pregnancy. Testing is recommended for individuals with compatible symptoms who have traveled to or live in an area with known Zika transmission, or for pregnant people with possible exposure. Healthcare providers may also test pregnant people with ongoing fever, rash, or other consistent symptoms even without known exposure. To reduce the chance of false results, timing of testing matters: viral RNA is best detected in blood within the first week, while antibody testing can support diagnosis later. If you are planning pregnancy or are pregnant and have concerns about recent travel or symptoms, discuss testing and preventive options with your clinician.